The long-term goal of the present application is the elucidation of the effects of estrogen on specific protein synthesis in the liver. The experimental model is the estrogen-treated cockerel. The estrogen regulated protein studied is apoVLDL-II, an estrogen induced protein first isolated in our laboratory. Previous studies indicate that a major factor in apoVLDL-II induction is the recruitment of liver cells not previously engaged in its synthesis. Control proteins comprise avian vitellogenin, apoA-1, ovalbumin, glycraldehyde 3 phosphate dehydrogenase and Beta-globin. They are chosen because they are either estrogen responsive, estrogen nonresponsive, or unexpressed in the avian liver and their cDNA clones are available. Isolated avian hepatocytes from untreated or estrogen-treated cockerels will be separated into subpopulations of cells that synthesize apoVLDL-II and those that do not. Techniques for cell separation include; (i) the use of the fluorescence activated cell sorter (FACS), and (ii) specific attachment of apoVLDL-II-synthesizing cells onto antibody immobilized on plastic plates. By these techniques at various times after estrogen, the proportion of hepatocytes which synthesize apoVLDL-II can be quantified accurately, and the relationship of the response to the cell cycle can be examined. The apoVLDL-II gene will be studied in untreated and estrogen-treated animals, and in the subpopulations of hepatocytes separated according to whether they synthesize apoVLDL-II or not. The apoVLDL-II gene will be studied in three ways: (i) its possible preferential enrichment in nuclear matrix, (ii) its DNAase I-hypersensitivity, and (iii) its methylation patterns. Specific nuclear estradiol binding sites will also be characterized in these subpopulations of cells. Furthermore, nuclear matrix isolated from these cells will also be examined for the presence of specific estrogen binding sites. Our approach should generate important new information on the molecular basis of the apoVLDL-II response to estrogen, and possibly the mechanisms underlying the heterogeneity of the response amongst different liver cell subpopulations.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL016512-12
Application #
3335218
Study Section
Physiological Chemistry Study Section (PC)
Project Start
1979-05-01
Project End
1989-04-30
Budget Start
1986-05-01
Budget End
1987-04-30
Support Year
12
Fiscal Year
1986
Total Cost
Indirect Cost
Name
Baylor College of Medicine
Department
Type
Schools of Medicine
DUNS #
074615394
City
Houston
State
TX
Country
United States
Zip Code
77030
Kojima, Hideto; Fujimiya, Mineko; Matsumura, Kazuhiro et al. (2004) Extrapancreatic insulin-producing cells in multiple organs in diabetes. Proc Natl Acad Sci U S A 101:2458-63
Pastore, Lucio; Belalcazar, L Maria; Oka, Kazuhiro et al. (2004) Helper-dependent adenoviral vector-mediated long-term expression of human apolipoprotein A-I reduces atherosclerosis in apo E-deficient mice. Gene 327:153-60
Oka, Kazuhiro; Chan, Lawrence (2004) Liver-directed gene therapy for dyslipidemia and diabetes. Curr Atheroscler Rep 6:203-9
Kojima, Hideto; Fujimiya, Mineko; Matsumura, Kazuhiro et al. (2003) NeuroD-betacellulin gene therapy induces islet neogenesis in the liver and reverses diabetes in mice. Nat Med 9:596-603
Belalcazar, L Maria; Merched, Aksam; Carr, Boyd et al. (2003) Long-term stable expression of human apolipoprotein A-I mediated by helper-dependent adenovirus gene transfer inhibits atherosclerosis progression and remodels atherosclerotic plaques in a mouse model of familial hypercholesterolemia. Circulation 107:2726-32
Liao, Wei; Chang, Benny Hung-Junn; Mancini, Michael et al. (2003) Ubiquitin-dependent and -independent proteasomal degradation of apoB associated with endoplasmic reticulum and Golgi apparatus, respectively, in HepG2 cells. J Cell Biochem 89:1019-29
Chan, Lawrence; Fujimiya, Mineko; Kojima, Hideto (2003) In vivo gene therapy for diabetes mellitus. Trends Mol Med 9:430-5
Serhan, Charles N; Jain, Ashish; Marleau, Sylvie et al. (2003) Reduced inflammation and tissue damage in transgenic rabbits overexpressing 15-lipoxygenase and endogenous anti-inflammatory lipid mediators. J Immunol 171:6856-65
Merched, Aksam J; Williams, Elizabeth; Chan, Lawrence (2003) Macrophage-specific p53 expression plays a crucial role in atherosclerosis development and plaque remodeling. Arterioscler Thromb Vasc Biol 23:1608-14
Ma, Ke; Cilingiroglu, Mehmet; Otvos, James D et al. (2003) Endothelial lipase is a major genetic determinant for high-density lipoprotein concentration, structure, and metabolism. Proc Natl Acad Sci U S A 100:2748-53

Showing the most recent 10 out of 87 publications